# Center for Engineering Complex Tissues

> **NIH NIH P41** · UNIV OF MARYLAND, COLLEGE PARK · 2020 · $1,149,071

## Abstract

Project Summary
The fabrication of complex engineered tissues remains a grand challenge in regenerative medicine. These
complex tissues – bone, cartilage, vasculature, and cardiac – are characterized by dense cellularity, patterned
cellular composition, and controlled matrix presentation. The proposed Biomedical Technology Resource
Center (BTRC) will address this critical need by applying three-dimensional printing (3DP) strategies to the
engineering of complex tissues. This BTRC brings together research leaders at the University of Maryland,
Rice University, and Wake Forest University, all highly regarded collaborators in the field, to lead the
development of the Center for Engineering Complex Tissues (CECT, [sees-t]). Strong and effective
administrative leadership will maximize productivity, enhance ongoing collaborations, and ensure sound fiscal
and compliance management for this BTRC. The technical components of CECT consist of 3 Technology
Research and Development Projects (TR&Ds), 6 Collaborative Projects (CPs), and 6 Service Projects (SPs).
An External Advisory Committee (EAC), that will guide and advise the strategic direction of the Center, will be
assembled from world-renowned researchers with biomedical expertise relevant to the CECT. A Local
Executive Committee (LEC) will coordinate the effort across the participating institutions involved in the day-to-
day operations of the Center. We will also focus on growing a community engaged in developing and utilizing
complex engineered tissues by offering a series of programs to help develop and establish these technologies.
Communications programs will also be developed for the dissemination of the Center’s activities to enable a
broader use of the technologies. The long-term plan for the CECT is that it will become a national hub for
transforming current 3DP and tissue engineering technologies into new and improved platforms for everyday
uses in regenerative medicine and biomedical device development.

## Key facts

- **NIH application ID:** 9860927
- **Project number:** 5P41EB023833-04
- **Recipient organization:** UNIV OF MARYLAND, COLLEGE PARK
- **Principal Investigator:** John P Fisher
- **Activity code:** P41 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $1,149,071
- **Award type:** 5
- **Project period:** 2017-04-15 → 2022-01-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9860927

## Citation

> US National Institutes of Health, RePORTER application 9860927, Center for Engineering Complex Tissues (5P41EB023833-04). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/9860927. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*